New Coronavirus Infection
DOI:
https://doi.org/10.62480/tjms.2023.vol16.pp60-63Keywords:
COVID-19, children, cardiovascular system, myocardial damageAbstract
COVID-19 (from the English Coronavirus disease 2019) is a new epidemic infectious disease characterized by a relatively high contagiousness and the likelihood of developing life-threatening complications in the form of acute respiratory distress syndrome, acute respiratory and multiple organ failure. a retrospective analysis of the incidence, clinical course and treatment of children with COVID-19 who were treated in a specialized hospital for the treatment of patients with coronavirus infection. We conducted a retrospective analysis of the case histories of 86 children of various ages who were hospitalized with a confirmed diagnosis of a new coronavirus infection COVID-19 in September-November 2020. There were 51 (%) boys, 34 (%) girls. Depending on age, patients were divided into 4 groups: up to 1 year - 7 (%), from 1 year to 6 years - 27 (%), from 7 to 12 years - 26 (%) and over 12 years - 26 (% ). Studies have shown that children with mild COVID-19 were treated on an outpatient basis and therefore were not included in the surveyed group. Children with moderate and severe forms of COVID-19 received inpatient treatment, and in our study, patients with moderate course - 57 (66.3%), and a severe course was noted in 29 (33.7%) children.
References
Alimova Kh.P., Rakhmanova D.I., Mardanova Kh.A. and others. Features of the clinical course of coronavirus infection in children // Infection, immunity and pharmacology. - 2021. - No. 4. - P. 34-39.
Zaplatnikov A.L., Svintsitskaya G.I. COVID-19 // GRM.- 2020.- No. 1.- P.1-3.
Ifran O., Tang K., Arin M., Bhutta Z.A. Epidemiology, characteristics and impact on children, adolescents and pregnant women // Pediatric pharmacology.- 2020.- V.17(4).- P.352-359. 4. Sabirov J.R., Khusanov A.M., Shamsutdinova M.I. and others. Health care in the era of a pandemic through the prism of time: international experience and achievements in the fight against COVID-19 // Infection, immunity and pharmacology.- 2021.- No. 4.- P.5-15.
Turabova N.R., Shamsutdinova M.I. Potential scenarios for the development of an immune response to a new type of coronavirus SARS-CoV-2 // Infection, immunity and pharmacology.- 2021.- No. 4.- P. 99-107.
Shamsheva O.V. New coronavirus COVID-19 (SARS-CoV-2) // Children's infections.- 2020.- V.19(1).- P.5-6.
Abduvaliev A.R., Inoyatova F.Kh., Mirkomilov E.M. A method of inhibiting t-helper 2 cells to prevent lung fibrosis that develops as a result of atypical pneumonia in COVID-19 // Proceeding of Global Congress of Contemporary Study- A Multidisciplinary International Scientific Conference Hosted from Pune, M.S. India.-P.182-187. www.econferenceglobe.com
CDC COVID-19 Response Team. Coronavirus disease 2019 in children. United States, February 12-April 2, 2020. MMWR Morb.Mortal Wkly Rep. 2020 Apr 6. http://dx.doi.org/10.15585/mmwr.mm6914e4.
Lu R., Zhao X., Li J, et al. Genomic characterization and epidemiology of 2019 novel cjrjnavirus: Implications for virus origins and receptor binding. // Lancet.- 2020.- Vol.395.- P.565-574.
Paules C.I., Eisinger R.W., Marston H.D., Fauci A.S. What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats. Ann Intern Med 2017; 167(11): 805–811.
United States Centers for Disease Control and Prevention. Cases in the US. https://coronavirus/2019-ncov/cases-updates/cases-in-uz.html
T.A Bobomuratov, M.A Bakirova, N.A Karimova, M.M Abdullaeva, Features of the Course of Covid-19 in Children of Different Ages (Based on RetrospectiveAnalysis) https://scholar.google.com/citations?view_op=view_citation&hl=ru&user=asb4pUsAAAAJ&citation_for_view=asb4pUsAAAAJ:u-x6o8ySG0sC
Каримова Н.А., Бобамуратов Т.А Евразийский вестник педиатрии 2/9/2021- Cardiovascular system changes in children suffered with covid-19 112-117
Бобомуратов Т.А., Каримова Н.А., Турсунбаев А.К. Вестник Ташкенской Медицинской Академи Течение коронавирусной инфекции у детей стр. 99-103
Бобомуратов Т.А ., Шарипова Д.Ж ., Султанова Н.С - Журнал «Интернаука» № 6 (229), 2022 г Features of the rehabilitation of children with covid-19 стр38-40
Каримова Н.А., Турсунбаев А.К. Academic research in educational sciences 2023/01 Заболевание COVID-19 у детей- стp 53-57
Бобомуратов Т.А., Каримова Н.А., Турсунбаев А.К.- Academic research in educational sciences 2023/01 Oсложнений со стороны сердечно-сосудистой системы у детей, перенесших covid-19 –стр 85-91
Bobomuratov, T. A., Nurmatova, N. F., Sultanova, N. S., Mallaev, S. S., & Fayziev, N. N. (2022). Brestfeeding and Genetic Features of Juvenile Rheumatoid Arthritis. Journal of Pharmaceutical Negative Results, 1983-1988.
Mallaev Sh.Sh, Bobomuratov T.A, Fayziev N.N., Sultanova N.S., Dinmuxammadieva D.R. Genetic Aspects of Juvenile Rheumatoid Arthritis. ISSN (E): 2795 – 7624 VOLUME 10 | JULY 2022. 1-5.
Sh.Sh Mallaev, T.A Bobomuratov, N.S.Sultanova, G.A.Yusupova, A.A.Hoshimov.// Сlinical characteristics and prediction of the outcome of juvenile rheumatoid arthritis in chronotherapy// Chin J Ind Hyg Occup Dis: Vol.39 (No.7). pp. 135-140.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
